In support of the HHS Bridge Access Program for COVID-19 Vaccines and Treatments, and in coordination with CDC's Bridge Access Program, HRSA will provide more than $81 million in one-time Bridge funding to active Expanding COVID-19 Vaccination (ECV/H8G) award recipients. These funds will help health centers continue providing essential COVID-19-related services (including support for equitable access to vaccines, therapeutics, and testing) to patients and residents of their community, including those who are uninsured or underinsured.<o:p></o:p>
HRSA plans to make awards using a formula-based supplement to the current H8G awards by Friday, September 1, 2023. These health centers will then have 30 days to submit information about their planned activities and costs related to this funding.<o:p></o:p>
HRSA will host a TA webinar soon after the release of funds. We will update the ECV TA webpage with the webinar details and Bridge funding guidance when the awards are released. Please submit questions using the BPHC Contact Form (COVID-19 Funding > ECV). <o:p></o:p>
If you have questions about how the Bridge program will make vaccines available for uninsured persons, consider attending our upcoming COVID-19 Response Program Office Hour sessions. While we will NOT discuss the Bridge ECV supplements at these sessions, we are inviting a CDC representative to join to discuss their program. Reminders:<o:p></o:p>
More Information Forthcoming...